Insomnia Disorder
3 competing products in clinical development for Insomnia Disorder.
Pipeline by Phase
Phase 11
Phase 21
Phase 31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| lemborexant + Placebo | Eisai | Phase 3 | Completed | 40 |
| ACT-541468 5 mg + ACT-541468 10 mg + ACT-541468 25 mg + Zolpidem + Placebo 1 + Placebo 2 | Idorsia | Phase 2 | Completed | 29 |
| Lemborexant 5 mg + Lemborexant 10 mg + Lemborexant-matched placebo. + Flurazepam 30 mg | Eisai | Phase 1 | Completed | 29 |